Expands COVID-19 Research Toolkit with novel hACE2 AC22 Mouse
RENSSELAER, N.Y., April 30 (Bernama-GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of a new COVID-19 mouse model. This human ACE2 (hACE2) transgenic mouse expands Taconic’s COVID-19 research toolkit.